documents: FDA-2019-D-5473-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-D-5473-0002 | FDA | FDA-2019-D-5473 | Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products Questions and Answers Guidance for Industry | Other | Guidance | 2020-02-04T05:00:00Z | 2020 | 2 | 2020-02-04T05:00:00Z | 2020-04-07T03:59:59Z | 2024-04-25T13:29:55Z | 0 | 0 | 0900006484325d68 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref